FOR RESEARCH USE ONLY.
If you are looking for Janoshik COAs, batch verification, supplier-screening standards, and an honest explanation of what testing does and does not prove, start here.
If you are new to the category, start with What Are Peptides?. If you want batch-specific verification, go to Lab Reports. If you want an evidence checklist for comparing documentation, use the research evaluation guide.
Documentation-only review path
For batch evidence, start with Lab Reports. For published literature context, use the Research Library. For a neutral checklist, use the research evaluation guide. Panda does not provide dosing, administration, treatment, or human-use guidance.
Panda’s Janoshik verification path
- Start with the Panda Peptides Janoshik COA verification hub.
- Match the compound name, batch identifier, and posted purity or content result.
- Use the direct Janoshik verification link where available to review the independent report outside Panda’s website.
This keeps the proof trail simple: product → batch COA → independent Janoshik verification. It is documentation for laboratory research materials, not protocol or use guidance.
Start with the proof, then the process
Review Lab Reports, compare them against the research evaluation guide, browse the Research Library, and use the FAQ for policy and ordering details.
At Panda Peptides, we believe customers deserve three things from a research company: honest sourcing, real third-party testing, and pricing that is fair.
Quality without vague trust badges
Verified before release. Published so you can check it.
Panda is not trying to win trust with a generic “99%+” badge. We publish the actual result for the tested batch, link to the independent Janoshik report where available, and explain what that report does — and does not — prove.
That sounds obvious, but in this industry it often is not.
A big part of why I started Panda Peptides was seeing how inconsistent this market can be. There are good suppliers out there, but there are also plenty who rely on polished marketing while the underlying product quality, documentation, or consistency does not meet the standard we believe customers deserve.
The fastest way to vet Panda
If you are comparing vendors and do not want to read everything, this is the shortest honest path.
- Open the Lab Reports directory and inspect the batch-level documentation first.
- Read About Panda Peptides, the research evaluation guide, and the FAQ to see how we present standards and policies in plain language.
- Then compare the product pages for GLP-3, GLP-1S, BPC-157, and Lipo-C against the documentation behind them.
That gives you our batch evidence, our operating standards, and our most-requested product paths without asking you to rely on generic trust badges.
1. We start by vetting suppliers, not just products
Before a product ever appears on our site, the process starts with supplier screening.
We receive constant outreach from manufacturers and intermediaries, but most do not meet our standards. We spend significant time evaluating suppliers, comparing communication quality, consistency, documentation, pricing, and overall reliability before we ever consider moving forward.
Our goal is not to find the cheapest source. Our goal is to find suppliers who can consistently deliver material that is good enough to put our name behind.
Even then, no supplier is perfect across every product or every batch. A supplier may perform well on one compound and poorly on another, or may be consistent for months and then have a batch that falls short. That reality is exactly why independent testing matters.
2. We build around batch-based purchasing
Once we identify suppliers we trust, we place larger batch orders rather than tiny one-off buys.
There is a reason for that. Proper third-party testing is expensive, and it only makes sense if we are building inventory around a real release process rather than buying small amounts ad hoc. Batch purchasing lets us combine better pricing for customers with a more structured quality-control workflow.
In plain English, we would rather build a real batch, test it, release it, and stand behind it than pretend every vendor lot is equally trustworthy.
3. We use third-party testing, not just our own claims
For the initial batches on our site, we used Janoshik Analytical, an independent third-party analytical laboratory that is widely recognized in this space.
That mattered to us for two reasons. First, we wanted testing from a recognized third party. Second, we wanted customers to be able to verify results outside our own website.
That second point is important. In this industry, fake COAs and edited screenshots are a real problem. A certificate image by itself is not enough. That is why we publish both a readable COA display on our site and a direct verification link to Janoshik whenever available.
When you open the Janoshik verification page, you will also see Panda branding tied to the report. We think that matters. It creates continuity between the batch we submitted, the report hosted by the lab, and the product page our customers are reviewing, which makes the verification process stronger and easier to trust.
You can review our current certificate library here: Lab Reports (COAs).
If you are comparing vendors, the best places to start are our Lab Reports, FAQ, About Panda Peptides page, research evaluation guide, and What Are Peptides? for a plain-language category overview. Together they show how we present testing, answer common policy questions, explain how the company operates, and frame what evidence a buyer should actually look for.
What our current testing covers
Our current release standard is focused on independent analytical verification: HPLC purity analysis and identity/composition confirmation as shown on the applicable Janoshik report. That is the evidence we can support today, and it is the evidence we publish.
Other quality markers — such as endotoxin screening, heavy-metal screening, sterility testing, residual solvents, or expanded contaminant panels — can be useful in laboratory quality programs, but we do not present them as universal Panda tests unless they are actually documented for the relevant product or batch. The point is simple: the page should say what the report proves, not what we wish the report proved.
4. We release products based on tested batches
Our current release model is batch-based.
Where products are filled from the same underlying batch material in different vial sizes, we may test a representative sample from that batch rather than every vial size individually. That approach reflects how the material is actually produced and keeps testing economically realistic at our current stage.
As we grow, our goal is to increase rigor further, including broader batch coverage, deeper documentation, and expanded test coverage where appropriate. For now, we would rather be precise about HPLC purity, identity confirmation, and batch-specific Janoshik verification than overstate the scope of testing.
5. We store and handle inventory with quality in mind
After release, products are stored under controlled conditions appropriate for the material, with a focus on minimizing avoidable degradation from heat, light, and poor handling.
We also take post-testing custody seriously. Once a research product leaves controlled custody, we cannot responsibly place it back into inventory. That protects future customers and helps preserve the integrity of the fulfillment process.
6. We are still improving the system
We are a growing company, and I want to be direct about that.
We have already identified improvements we plan to roll out over time in how we present testing, batch information, and quality documentation. Some of that is about better customer clarity. Some of it is about making independent verification easier. Some of it is about adding more rigor as scale allows.
That is how we intend to build this business: not by pretending the process is perfect on day one, but by being transparent, improving steadily, and keeping customers first.
7. Why we do it this way
Panda Peptides exists because I believed there was room for a company that took quality seriously without charging inflated prices just because the market would tolerate it.
Some companies do good work, but price far above what I think is reasonable. Others compete on price and cut too many corners. We are trying to do something different: offer strong sourcing, real testing, honest communication, and service that actually respects the customer.
That is the standard we are building toward every day.
Cory
Founder, Panda Peptides